Reported June 18,
2003
Future Benefits of Intensive
Diabetes Control
By Stacie Overton,
Ivanhoe Health Correspondent
NEW ORLEANS (Ivanhoe
Newswire) -- New research
presented at this year’s Annual
Meeting of the American Diabetes
Association shows tight control
of type 1 diabetes has more
impact than was once thought.
Even if blood sugar control
decreases over time, researchers
now know patients who have tight
control early on in their
disease have reduced
atherosclerosis and other
complications years later. David
Nathan, M.D., from Harvard, and
John Lachin, ScD, from George
Washington University, presented
the new information. The
Diabetes Control and
Complications Trial began 20
years ago with 1,441 people with
type 1 diabetes. Patients either
had intensive control,
consisting of several insulin
injections and blood sugar
checks throughout the day, or
conventional control, which
consisted of only one or two
injections and blood checks
daily. Results of that study
show the intensive therapy group
had fewer complications and
significantly better blood sugar
control.
In a study following up on
the DCCT, researchers found the
blood sugar levels of patients
from the intensive control group
raised slightly over the
subsequent eight years, while in
the conventional group, average
blood sugar levels lowered
slightly. Thus, the two groups
had similar blood sugar levels
and control eight years later.
Now, new information shows
even though their current
disease control was similar,
those who were previously
maintaining intensive control
have significantly less
calcification in their coronary
arteries than those who were on
conventional control. Lachin
explained, “Intensive control,
bringing blood glucose levels as
close to normal as possible for
an average of six and a half
years, yielded reduced
atherosclerosis even followed by
eight years of less effective
control, compared to those who
never achieved tight control.”
Dr. Nathan says those
formerly on intensive therapy
have also continued to display a
significantly reduced
progression of microvascular
disease (vision damage, nerve
damage and kidney damage). He
says this persistent effect of
former blood sugar control
cannot be easily explained by
any acute effect of blood sugar
levels. He says, “Metabolic
memory may be the best model for
understanding the results.”
Lachin concurred, saying,
“What we’re seeing is this
profound effect of glycemia on
the long-term risk of
complications.” He continued,
“The critical message of this
research is that good glucose
control should be implemented as
early as possible. A high A1C
level (average blood sugar over
three months) causes the
greatest damage in the first few
years of diabetes.”
This article was reported by
Ivanhoe.com, who offers Medical
Alerts by e-mail every day of
the week. To subscribe, go to:
http://www.ivanhoe.com/newsalert/.
SOURCE: Reported at the 63rd
Annual Meeting of the American
Diabetes Association, New
Orleans, June 13-17, 2003